PLRX
NASDAQ · Pharmaceuticals
Pliant Therapeutics Inc
$1.04
-0.01 (-0.95%)
Analyst Consensus
Strong Sell
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,542.3% upside
Low Target
$13.48
Average Target
$17.08
High Target
$25.30
Current Price
$1.04
Current
$1.04
$1.04
Target
$17.08
$17.08
$13.48
$17.08 avg
$25.30
Scenario Analysis
Bear Case
$13.48
1,196.2%
Low target
Base Case
$17.08
+1,542.3%
Avg target
Bull Case
$25.30
+2,332.7%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$1.95
-46.7% from high
52-Week Low
$1.03
+1.0% from low
Target vs 52W High
$17.08
+775.9% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-0.35
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals